Products/Services Used | Details | Operation |
---|---|---|
Gene Synthesis> | … Restriction enzymes were from New England Biolabs. Gene synthesis and plasmid constructs were acquired from Genscript. Hi-trap protein-chromatographic columns were acquired from GE Healthcare. E. coli Bl21 pLys-DE3 strain was from Promega. 2.2 … | Get A Quote |
DapE is an enzyme that belongs to the meso-diaminopimelate/Lysine pathway. It is recognized as an antimicrobial target, hence compounds that inhibit its catalytic activity are required. The principal features considered in the selection of potential inhibitors for this enzyme are compounds containing metal binding groups that could block access of the substrate to the Zinc metal centers and/or block the assembly of the oxyanion hole. We show the interaction of DapE from Enterococcus faecium, Staphylococcus aureus, Klebsiella aerogenes, Pseudomonas aeruginosa and Escherichia coli with flavonoids: quercetin, catechin, luteolin, rutin and hesperidin. Flavonoids contain several oxygen atoms distributed along their ... More